Non-transfusion-dependent thalassemia encompasses three clinically distinct forms -- beta-thalassaemia intermedia, hemoglobin E/beta-thalassaemia (mild and moderate forms), and al ...

Commissioner Sargodha Division Jahanzeb Awan visited the Thalassemia and Hemophilia Centre at Hilal-e-Ahmer Hospital to review the ...

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

DKMS Foundation India inaugurates new BMT unit in Ahmedabad, providing hope and treatment for thalassemia patients in Gujarat ...

Tharu tribals face higher rates of thalassemia (22-24%) and sickle cell anaemia (60%) than the general population, prompting a medical camp for 2 lakh people.

Cash, cash equivalents and marketable securities as of December 31, 2024, were $1.5 billion compared to $806.4 million as of December 31, 2023.

As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...

A Thalassemia screening desk has been inaugurated at the NADRA centre in Sukkur on Saturday marking a significant step ...

Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...

Stem cell transplants play a vital role in treating people affected by blood cancers and disorders such as thalassemia.